Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Cappuzzo

Showing results (71-80 of 275) with videos related to

Pageof 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
Primary pulmonary meningioma: report of a case and review of the literatureMatteo Incarbone, Giovanni Luca Ceresoli, Luca Di Tommaso, et al.
The Oncologist|March 11, 2023
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical TrialsLee X Li, Federico Cappuzzo, Ignacio Matos, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2025
BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile?Filippo Tommaso Gallina, Fabiana Letizia Cecere, Serenella Bergomi, et al.
Frontiers in Oncology|July 31, 2023
Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitorsAlessio Annovazzi, Sandra Rea, Daria Maccora, et al.
The Oncologist|October 9, 2010
Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimensFrancesco Grossi, Kaoru Kubota, Federico Cappuzzo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN studyJulien Mazières, Wolfram Brugger, Federico Cappuzzo, et al.
Surgery Today|September 21, 2023
Could the molecular profile aid in predicting occult nodal metastasis in early-stage lung adenocarcinoma?Filippo Tommaso Gallina, Fabiana Letizia Cecere, Riccardo Tajè, et al.
Cancers|March 28, 2015
cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the ResistanceNele Van Der Steen, Patrick Pauwels, Ignacio Gil-Bazo, et al.
Translational Lung Cancer Research|July 18, 2017
Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Andrea Ardizzoni, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 20, 2025
The effects of race on anti-PD-(L)1 monoclonal antibodies in non-small cell lung cancer: A systematic literature review and meta-analysisCarlo Genova, Federico Cappuzzo, Giorgio Minotti, et al.
Pageof 28

Showing results (71-80 of 275) with videos related to

Sort By:
Pageof 28
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
Primary pulmonary meningioma: report of a case and review of the literatureMatteo Incarbone, Giovanni Luca Ceresoli, Luca Di Tommaso, et al.
The Oncologist|March 11, 2023
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical TrialsLee X Li, Federico Cappuzzo, Ignacio Matos, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2025
BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile?Filippo Tommaso Gallina, Fabiana Letizia Cecere, Serenella Bergomi, et al.
Frontiers in Oncology|July 31, 2023
Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitorsAlessio Annovazzi, Sandra Rea, Daria Maccora, et al.
The Oncologist|October 9, 2010
Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimensFrancesco Grossi, Kaoru Kubota, Federico Cappuzzo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN studyJulien Mazières, Wolfram Brugger, Federico Cappuzzo, et al.
Surgery Today|September 21, 2023
Could the molecular profile aid in predicting occult nodal metastasis in early-stage lung adenocarcinoma?Filippo Tommaso Gallina, Fabiana Letizia Cecere, Riccardo Tajè, et al.
Cancers|March 28, 2015
cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the ResistanceNele Van Der Steen, Patrick Pauwels, Ignacio Gil-Bazo, et al.
Translational Lung Cancer Research|July 18, 2017
Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Andrea Ardizzoni, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 20, 2025
The effects of race on anti-PD-(L)1 monoclonal antibodies in non-small cell lung cancer: A systematic literature review and meta-analysisCarlo Genova, Federico Cappuzzo, Giorgio Minotti, et al.
Pageof 28